With the FDA approval of Zepbound (tirzepatide) for obstructive sleep apnea, GLP-1 receptor agonists harbor potential beyond weight and diabetes management.

The EULAR released a 2024 update to the existing guidance on antirheumatic drug use during family planning, pregnancy, breastfeeding, and fertility treatment.

With clinical trials investigating novel immunomodulatory approaches, the therapeutic landscape for treating vasculitis continues to evolve.

We spoke with rheumatology patient Stacy Courtnay, who shared her experience being pregnant while living with rheumatoid arthritis.

What are the gaps in the management of musculoskeletal health during the menopausal transition?